Iain B. McInnes - 08 Jun 2023 Form 4 Insider Report for Evelo Biosciences, Inc.

Role
Director
Signature
/s/ Marella Thorell, Attorney-in-Fact for Iain B. McInnes
Issuer symbol
EVLO on OTC
Transactions as of
08 Jun 2023
Net transactions value
$0
Form type
4
Filing time
12 Jun 2023, 16:05:16 UTC
Previous filing
13 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVLO Stock Option (Right to Buy) Award $0 +20,000 $0.000000 20,000 08 Jun 2023 Common Stock 20,000 $0.1100 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests on the earlier of June 8, 2024, and the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of the grant.

Remarks:

Exhibit 24: Power of Attorney